SPDR SP Financial Statements From 2010 to 2026
| XBI Etf | USD 125.51 4.79 3.97% |
Check SPDR SP financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among SPDR SP's main balance sheet or income statement drivers, such as , as well as many indicators such as . SPDR financial statements analysis is a perfect complement when working with SPDR SP Valuation or Volatility modules.
This module can also supplement various SPDR SP Technical models . Check out the analysis of SPDR SP Correlation against competitors. Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of SPDR SP Correlation against competitors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
SPDR SP Biotech's market price often diverges from its book value, the accounting figure shown on SPDR's balance sheet. Smart investors calculate SPDR SP's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since SPDR SP's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between SPDR SP's value and its price as these two are different measures arrived at by different means. Investors typically determine if SPDR SP is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SPDR SP's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.